GLUCOCORTICOID EFFECTS IN THE HUMAN PLACENTA - EVIDENCE THAT DEXAMETHASONE-MEDIATED INHIBITION OF FIBRONECTIN EXPRESSION IN CYTOTROPHOBLASTS INVOLVES A PROTEIN INTERMEDIATE
Dy. Yoon et al., GLUCOCORTICOID EFFECTS IN THE HUMAN PLACENTA - EVIDENCE THAT DEXAMETHASONE-MEDIATED INHIBITION OF FIBRONECTIN EXPRESSION IN CYTOTROPHOBLASTS INVOLVES A PROTEIN INTERMEDIATE, The Journal of clinical endocrinology and metabolism, 83(2), 1998, pp. 632-637
Oncofetal fibronectin is an extracellular matrix protein that is sugge
sted to play an important role in regulating adherence at uterine-plac
ental interfaces. The purpose of the present study was to elucidate a
mechanism through which glucocorticoids (GCs) inhibit the synthesis of
FN in human placenta as part of their matrix-suppressive action near
parturition. We observed that treatment of cytotrophoblasts isolated f
rom human term placentas for 48 h with 10(-7) mol/L dexamethasone (DEX
) down-regulated levels of FN expression to 13-19% of control levels i
n immunoprecipitation, Northern blotting, and enzyme-linked immunosorb
ent assay experiments. Conversely, GC treatment increased FN expressio
n in placental fibroblasts to 164-310% of control levels in Northern b
lotting and enzyme-linked immunosorbent assay procedures, suggesting t
hat CC-mediated suppression of FN expression is specific to cytotropho
blasts. Results indicated that the DEX-mediated suppression of FN expr
ession in cytotrophoblasts was not mediated through changes in the sta
bility of FN messenger ribonucleic acid (mRNA). Run-on transcription a
ssays using isolated nuclei suggested that GC treatment did not marked
ly affect transcription of the FN gene in cytotrophoblasts. To test wh
ether the CC-mediated suppression of FN expression was mediated throug
h a protein intermediate, levels of FN mRNA were examined by Northern
blotting in Cells treated for 48 h with and without 10(-7) mol/L DEX a
nd cycloheximide (CHX; 125 ng/mL). We observed that CHX treatment incr
eased FN expression in DEX-treated cells to 91% of control values. We
noted that whereas the presence of 100-300 ng/mL CHX reversed the DEX-
mediated inhibition of FN mRNA expression in cytotrophoblasts, it did
not alter the overall rates of protein synthesis in DEX-treated and co
ntrol cells. These data suggest that suppression of FN mRNA expression
by GC in cytotrophoblasts requires de novo protein synthesis and is m
ediated through a short lived intermediate, the synthesis of which is
inhibited at low concentrations of CHX. Thus, CC-induced protein inter
mediates may influence uterine-placental adherence by modulating level
s of oncofetal FN at sites of uterine-placental contact.